About this trial
This is a randomized, open-label, multi-center clinical study aimed at evaluating the efficacy and safety of 12 weeks of nalfurafine hydrochloride administration in the treatment of pruritus in patients undergoing maintenance hemodialysis.
Eligibility criteria
Qualifiers
Age range of 18-80 years old (including both ends), male or female not limited.
Chronic renal failure patients who undergo stable dialysis for 3 months or more, receive regular hemodialysis 3 times a week, and are expected to have no significant changes in treatment or rapid changes in their condition during the clinical trial period.
Within one year prior to signing the informed consent form, the effectiveness of itch treatment (including topical medications such as moisturizers/moisturizers, systemic medications such as antihistamines or antiepileptic drugs, and non pharmacological treatments) was not satisfactory.
Those who are able to understand and comply with the research procedures and methods, voluntarily participate in this study, and sign a written informed consent form.
Disqualifiers
Given poor compliance with dialysis treatment, researchers believe that it may affect the effectiveness and safety of clinical studies.
Patients who plan to undergo kidney transplantation or other elective surgeries during the study period.
Patients with alanine aminotransferase (ALT), aspartate aminotransferase (AST), or glutamine transferase (GGT) levels exceeding the upper limit of normal (ULN) by 2 times, or total bilirubin levels exceeding the upper limit of normal (ULN) by 2 times during the screening period.
Skin itching is not caused by chronic kidney disease, including allergic skin diseases (atopic dermatitis, urticaria, eczema, drug rash, etc.), physical skin diseases (prickly heat, solar rash, etc.), infectious skin diseases (insect bite dermatitis, chickenpox, measles, pyoderma, tinea corporis, etc.), cholestatic liver disease, etc.
Trial design
Treatments tested in this trial
- Nalfurafine Hydrochloride
- Basic treatment
Treatment groups
Sponsors and collaborators
Chinese PLA General Hospital
Lead sponsor
The First Affiliated Hospital of Dalian Medical University
Collaborator
Beijing Friendship Hospital
Collaborator
The General Hospital of Northern Theater Command
Collaborator
Tianjin First Central Hospital
Collaborator
RenJi Hospital
Collaborator
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Collaborator
Xiangyang Central Hospital
Collaborator
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Collaborator
Jiangsu Taizhou People's Hospital
Collaborator
Qilu Hospital of Shandong University
Collaborator
First Affiliated Hospital Xi'an Jiaotong University
Collaborator
Zigong No.1 Peoples Hospital
Collaborator
Chengdu First People's Hospital
Collaborator
The People's Hospital of Leshan
Collaborator
The Third Affiliated Hospital of Wenzhou Medical University
Collaborator
Henan Provincial People's Hospital
Collaborator
Shanghai Changzheng Hospital
Collaborator
Daping Hospital of Army Medical University
Collaborator
First Affiliated Hospital of Wannan Medical College
Collaborator